randomly assigned 55 patients with biopsy-confirmed NASH and either impaired glucose tolerance or type 2 diabetes to receive a hypocaloric diet plus either pioglitazone (30 mg daily for 2 months ...

The aim of this study was to investigate whether treatment with pioglitazone in an unselected population of patients with type 2 diabetes results in comparable blood pressure benefits to those ...

Whether premenopausal women are, in fact, protected from the adverse effects of pioglitazone treatment has not been investigated. This double-blind study compared 30 white women with PCOS who had ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...